Composition for Treating Pulmonary Fibrosis

The present invention relates to a therapeutic composition comprising a compound having excellent therapeutic efficacy for pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF) of unknown cause or pulmonary fibrosis caused by COVID-19. 본 발명은 폐섬유화증(Pulmonary Fibrosis), 특히 원인불명의 특발성 폐섬유화증...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YUN CHI HO, KIM MIN KYOUNG
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a therapeutic composition comprising a compound having excellent therapeutic efficacy for pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF) of unknown cause or pulmonary fibrosis caused by COVID-19. 본 발명은 폐섬유화증(Pulmonary Fibrosis), 특히 원인불명의 특발성 폐섬유화증(Idiopathic Pulmonary Fibrosis, IPF)이나, 코로나바이러스감염증-19로 인한 폐섬유화증에 대한 우수한 치료 효능을 갖는 화합물을 포함하는 치료용 조성물에 대한 것이다.